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Background/aim: To develop a novel polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) protocol
using a new genomic marker sequence and a novel set of restriction enzymes in order to detect and discriminate 2 Echinococcus species,
E. granulosus and E. multilocularis, found in formalin-fixed paraffin-embedded (FFPE) human tissues.
Materials and methods: DNA was isolated from 11 FFPE human tissue samples positive for cystic echinococcosis or alveolar
echinococcosis. A mitochondrial genomic marker region was amplified and sequenced using a novel primer pair and a new PCR-RFLP
protocol was developed for the detection and discrimination of E. granulosus and E. multilocularis using a set of restriction enzymes
including AccI, MboI, MboII, and TsoI.
Results: The selected marker region was amplified using DNA isolated from FFPE human tissue samples positive for cystic echinococcosis
or alveolar echinococcosis and the discrimination of E. granulosus and E. multilocularis was accomplished by use of the novel PCR-RFLP
method.
Conclusion: In this PCR-RFLP protocol, use of any single restriction enzyme is enough for the discrimination of E. granulosus and E.
multilocularis. The PCR-RFLP protocol can be potentially used for the discrimination of 5 other Echinococcus species: E. oligarthus, E.
shiquicus, E. ortleppi, E. canadensis, and E. vogeli.
Key words: FFPE tissues, Echinococcus granulosus, Echinococcus multilocularis, sequencing, PCR-RFLP

1. Introduction
Echinococcosis is a cosmopolitan zoonosis caused
by adult or larval stages of cestodes belonging to the
genus Echinococcus. The 2 major species of medical and
public health importance are Echinococcus granulosus
and Echinococcus multilocularis, which cause cystic
echinococcosis (CE) and alveolar echinococcosis (AE),
respectively (1–4).
The diagnostic procedure for CE as well as for AE includes
clinical, radiological, and particularly serological examinations
(2). Ultrasonography, computer tomography, and magnetic
resonance are used in radiological diagnosis (5,6). Indirect
hemagglutination, indirect fluorescent antibody test, and
enzyme linked immunosorbent assay are used in serological
* Correspondence: skuk@erciyes.edu.tr

diagnosis (7,8). However, the definitive diagnosis is usually
based on pathological-histological analysis of particularly
periodic acid–Schiff-stained specimens of surgically resected
tissues (9). On the other hand, histological examinations
are hampered by some difficulties. First, sometimes
Echinococcus cysts are sterile, making the diagnosis of cysts
difficult. It is also possible in some cases to have difficulties
in the discrimination of E. granulosus and E. multilocularis.
In addition, subgenotypes of E. granulosus (G1–G10) and
subspecies of E. multilocularis can be discriminated using
molecular methods, although discrimination is not possible
using histological methods (10).
Molecular methods, unlike classical histopathological
methods, can both detect and discriminate Echinococcus
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species. Cyst liquid, cyst membrane, and protoscolex
were used in many previous studies on Echinococcus
phylogenetics (11). However, fresh materials from humans
are only available in regions where the disease is endemic
(12). Therefore, instead of fresh material, formalin-fixed
and paraffin-embedded tissues (FFPETs) are commonly
used in molecular studies. FFPETs represent the most
important specimens for diagnostic surgical pathology
and, moreover, have proven to be an invaluable source for
retrospective studies. Moreover, paraffin blocks are easy to
store for long periods and to transport to the laboratory
(11,12).
In contrast to classical histopathological examinations,
molecular methods provide the opportunity to conclusively
determine species as well as strains within the genus
Echinococcus, which causes serious diseases worldwide.
Molecular examinations mostly focus on mitochondrial
and nuclear genomic sequences and sequences such as
cox1, cytochrome c oxidase subunit 1; nad1, NADH
dehydrogenase subunit 1; atp6, ATPase subunit 6; cob,
cytochrome b; and rrnL, large-subunit rRNA, and these
sequences have been used as markers. Polymerase chain
reaction-restriction fragment length polymorphism
(PCR-RFLP) is one of the common methods to
discriminate Echinococcus species and subspecies (13–
15). In PCR-RFLP, a marker region is amplified by PCR
and the amplified DNA fragment is digested by specific
restriction enzymes. Different sizes of digestion products
will discriminate between different species. Lately, in
depth analyses of DNA by sequencing and multiplex PCR
have been extensively performed for the identification and
phylogenetic classification of Echinococcus species. These
studies utilized the complete mitochondrial genome or
nuclear and mitochondrial markers (16–18).
In this study, we designed a novel primer pair for
sequencing analysis. We developed a new PCR-RFLP
protocol using a new genomic marker sequence and a
novel set of restriction enzymes in order to detect and
discriminate 2 Echinococcus species, E. granulosus and E.
multilocularis, found in human FFPETs.
2. Materials and methods
2.1. Collection of samples
In this study FFPET samples were used. Ten FFPET samples
histomorphologically positive for CE and 1 FFPET sample
positive for AE were obtained. Genomic DNA for E.
multilocularis was a kind gift from Dr Bruno Gottstein. All
tissue samples were confirmed to be Echinococcus-positive
by histomorphological analysis. Samples were obtained
from the Department of Pathology of the Medical Faculty
of Fırat University and from the Medical Faculty of Erciyes
University. This study was approved by the Elazığ Clinical
Investigations Institutional Ethics Committee.
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2.2. DNA isolation
Deparaffinization and dehydration of FFPET samples
were performed. Seven embedded tissue slices of 10 µm
in size were collected. These pieces were deparaffinized
in 1 mL of xylene at 65 °C for 10 min. The samples were
centrifuged at 3500 rpm for 5 min and the supernatant was
discarded (this step was repeated 5 times). Dehydration
was performed using 70%, 80%, 90%, and 100% ethanol,
respectively.
DNA isolation from FFPET samples was performed
using the Wizard Genomic DNA Purification Kit (Promega,
USA) by modifying the proteinase K step. The modified
step was as follows: each sample was incubated in 600 µL
of EDTA/Nuclei Lysis Solution and 15 µL of proteinase K
(Sigma, Germany) at 55 °C in a shaker water bath for 48 h.
At 12-h intervals, 5 µL of fresh proteinase K (50 mg/mL)
was added. In the last step, DNA was resuspended in 100
µL of DNA rehydration solution and stored at –20 °C.
2.3. Primer design and PCR
The mitochondrial genomic region of 871 bp was PCRamplified using the genomic DNA extracted from FFPET
samples. The amplified genomic region spans the last
part of a large ribosomal RNA gene, the cysteine tRNA
gene, and the beginning of a small ribosomal RNA
gene. We designed novel primers as follows: PEmg F
(5’-GTTAAGTTACCCTAGGGATAAC-3’) and PEmg R
(5’- TACTATTAAGTCCTAAA-3’) (Figures 1A and 1B).
In PCR reactions, 12.5 µL of 2X master mix (Vivantis,
Malaysia), 2 µL of 20 pmol PEmg FR primers, 1 µL of
genomic DNA, and 9.5 µL of distilled water were used for
25 µL of reaction mix. PCR conditions were as follows: 1)
hot start at 95 °C for 5 min; 2) 35 cycles of denaturation at
94 °C for 1 min, annealing at 42 °C for 1 min, and extension
at 72 °C for 1 min; and 3) final extension at 72 °C for 10
min. Amplicons obtained by PCR amplification were run
in 1.5% agarose gel at 120 V for 30 min and visualized in
Gel Logic 212 PRO (Carestream, USA). Amplicons were
purified using the GF-1 AmbiClean Kit (Vivantis) before
moving forward to the restriction digestion analysis.
2.4. DNA sequencing
PCR products were sequenced and confirmed. The
purified products were subjected to cycle sequencing by
the dideoxynucleotide chain termination method using
the DYEnamic ET Terminator Cycle Sequencing Kit
(Amersham, USA), with PEmg F and PEmg R primers
as sequencing primers. The products were separated in
an automated DNA genetic analyzer (MegaBACE 500
Genetic Analyzer). The GenBank BLAST program was
used for comparisons.
2.5. Restriction fragment length polymorphism
Purified PCR products were cut by the following restriction
enzymes: TsoI (Fermentas, USA), MboI (BIORON,

ŞAKALAR et al. / Turk J Med Sci
Germany), MboII (Fermentas), and AccI (Fermentas).
Restriction reactions were performed in 20 µL using
approximately 0.5–1 µg DNA with the following conditions
for each enzyme: TsoI, 3 units at 55 °C for 16 h; MboI, 10
units at 37 °C for 1.5 h; MboII, 2.5 units at 37 °C for 1.5 h;
and AccI: 10 units at 37 °C for 16 h. Digestion products
were separated in 2% (w/v) agarose gels, visualized in Gel
Logic 212 PRO, and photographed.
3. Results
3.1. Amplification of the mitochondrial genomic region
of E. granulosus and E. multilocularis
Genomic DNA from FFPET samples was isolated and used
for the following experiments. A pair of novel primers was
designed to amplify a selected mitochondrial genomic
region of both E. granulosus (9171–10,042 bp) and E.
multilocularis (11,585–12,461 bp). The genomic region of
approximately 875 bp spans the last part of a large ribosomal
RNA gene, cysteine tRNA gene, and the beginning of
a small ribosomal RNA gene. Restriction enzymes that
differentially digest the amplified mitochondrial genomic
region of E. granulosus and E. multilocularis were selected.
The DNA sequence of the amplified genomic region of E.
granulosus and E. multilocularis and restriction enzyme
sites used on this sequence are depicted in Figure 1.
PCR fragments amplified using the designed primers
were sequenced for confirmation. E. granulosus and
E. multilocularis were clearly discriminated based on
sequencing results (Figure 1). Confirmed PCR products
were purified and used for the RFLP analysis.

3.2. Restriction fragment length polymorphism
Four DNA restriction enzymes were selected to digest
the amplified genomic region. PCR fragments amplified
using E. multilocularis and E. granulosus genomic DNA
were digested with each of selected restriction enzymes.
Restriction digestion products and uncut controls that
were not digested with restriction enzymes were visualized.
The PCR fragment amplified using E. multilocularis
genomic DNA as the template was digested by MboI and
the digestion resulted in DNA fragments with sizes of
788 bp and 89 bp. The PCR fragment amplified using E.
granulosus genomic DNA as the template was digested by
MboI; the digestion did not result in any digested DNA
fragments and only the uncut full-length PCR fragment
was visualized (Figure 2). The PCR fragment amplified
using E. multilocularis genomic DNA as the template
was digested by MboII and the digestion resulted in DNA
fragments with sizes of 690 bp and 187 bp. The PCR
fragment amplified using E. granulosus genomic DNA as
the template was digested by MboII; the digestion did not
result in any digested DNA fragments and only the uncut
full-length PCR fragment was visualized (Figure 3). The
PCR fragment amplified using E. multilocularis genomic
DNA as the template was digested by AccI and the digestion
resulted in DNA fragments with sizes of 660 bp and 217 bp.
The PCR fragment amplified using E. granulosus genomic
DNA as the template was digested by AccI; the digestion
did not result in any digested DNA fragments and only
the uncut full-length PCR fragment was visualized (Figure
4). In contrast, the PCR fragment amplified using E.
multilocularis genomic DNA as the template was digested

Figure 1. Map of restriction enzyme sites in the amplified mitochondrial genome region of A) E. granulosus and B) E. multilocularis.
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Figure 2. A mitochondrial genomic region was amplified using E. multilocularis (E.m.)
and E. granulosus (E.g.) genomic DNA, digested with MboI, and visualized. From left to
right, lane M is the DNA ladder, the second and third lanes are uncut controls, and the
fourth and fifth lanes are PCR fragments digested with MboI. The digestion of the PCR
fragment produced using E.m. genomic DNA as the template resulted in 2 digestion
products of 788 bp and 89 bp as visualized in the fourth lane. The digestion of the
PCR fragment produced using E.g. genomic DNA as the template did not result in any
restriction fragment as visualized in the fifth lane.
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Figure 3. A mitochondrial genomic region was amplified using E. multilocularis
(E.m.) and E. granulosus (E.g.) genomic DNA, digested with MboII, and visualized.
From left to right, lane M is the DNA ladder, the second and third lanes are uncut
controls, and the fourth and fifth lanes are PCR fragments digested with MboII. The
digestion of the PCR fragment produced using E.m. genomic DNA as the template
resulted in 2 digestion products of 690 bp and 187 bp as visualized in the fifth lane.
The digestion of the PCR fragment produced using E.g. genomic DNA as the template
did not result in any restriction fragment as visualized in the fourth lane.

by TsoI and the digestion did not result in any digested
DNA fragments. The PCR fragment amplified using E.
granulosus genomic DNA as the template was digested by
TsoI and the digestion resulted in DNA fragments with
sizes of 362 bp and 510 bp (Figure 5).

744

4. Discussion
Genomic DNA was obtained from FFPET samples. FFPET
samples are among the most commonly used and available
samples. Use of FFPET samples in molecular studies
has increased significantly. It is crucial to be able to use
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Figure 4. A mitochondrial genomic region was amplified using E. multilocularis (E.m.)
and E. granulosus (E.g.) genomic DNA, digested with AccI, and visualized. From left to
right, lane M is the DNA ladder, the second and third lanes are uncut controls, and the
fourth and fifth lanes are PCR fragments digested with AccI. The digestion of the PCR
fragment produced using E.m. genomic DNA as the template resulted in 2 digestion
products of 660 bp and 217 bp as visualized in the fifth lane. The digestion of the PCR
fragment produced using E.g. genomic DNA as the template did not result in any
restriction fragment as visualized in the fourth lane.
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Figure 5. A mitochondrial genomic region was amplified using E. multilocularis (E.m.)
and E. granulosus (E.g.) genomic DNA, digested with TsoI, and visualized. From left to
right, lane M is the DNA ladder, the second and third lanes are uncut controls, and the
fourth and fifth lanes are PCR fragments digested with TsoI. The digestion of the PCR
fragment produced using E.g. genomic DNA as the template resulted in 2 digestion
products of 510 bp and 362 bp as visualized in the fifth lane. The digestion of the PCR
fragment produced using E.m. genomic DNA as the template did not result in any
restriction fragment as visualized in the fourth lane.

DNA isolated from FFPET samples to do further PCR

possible to amplify the target genomic region using the

amplifications and RFLP analysis (10). In this study, it was

DNA from FFPET samples.
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Molecular methods were developed in order to
detect and discriminate Echinococcus species by making
use of mitochondrial and nuclear genomic sequences.
Characterization of E. granulosus was attempted by PCRRFLP using an ITS-1 DNA sequence in Iran, an endemic
region (19). The discrimination of E. granulosus and E.
multilocularis and specific discrimination of E. granulosus
strains have been performed by PCR-RFLP (20).
Mitochondrial and nuclear markers (cox1, cytochrome c
oxidase subunit 1; nad1, NADH dehydrogenase subunit
1; atp6, ATPase subunit 6; cob, cytochrome b; rrnL, largesubunit rRNA) were used in the genetic characterization
of Echinococcus shiquicus (21). The discrimination of
taeniid cestode species including E. granulosus and E.
multilocularis has been done by PCR-RFLP of ITS-2
ribosomal DNA (22). Another PCR-RFLP method for
the identification of the 3 species of E. granulosus, E.
multilocularis, and E. shiquicus utilizes the species-specific
SspI digestion of a large subunit of ribosomal RNA gene
rrnL (23).
In this study, we designed a novel primer pair that
can amplify a genomic marker region containing the last
part of a large ribosomal RNA gene and the beginning
of a small ribosomal RNA gene in both E. multilocularis
and E. granulosus. Additionally, it is possible to amplify
the same genomic region with the same primer pair
using the genomic DNA of several other species such as
E. oligarthus, E. shiquicus, E. ortleppi, E. canadensis, and
E. vogeli. We sequenced the amplified PCR product using
the DNA isolated from Echinococcus-positive human
FFPET samples and did the molecular discrimination of
E. multilocularis and E. granulosus based on sequencing
results (Figure 1). It is also possible to discriminate other
Echinococcus species by PCR and sequencing using this
novel set of primer pairs.

We also developed a new PCR-RFLP using the same
genomic region amplified by our primer set to discriminate
E. multilocularis and E. granulosus. This PCR-RFLP
method can be used to discriminate other Echinococcus
species including E. oligarthus, E. shiquicus, E. ortleppi,
E. canadensis, and E. vogeli (Table). We used 4 different
restriction enzymes to discriminate E. multilocularis and
E. granulosus. Three of these enzymes (MboI, MboII, and
AccI) were only able to digest the PCR fragment produced
using the genomic DNA of E. multilocularis and the other
enzyme (TsoI) was only able to digest the PCR fragment
produced using the genomic DNA of E. granulosus. We
showed that it is possible to decide whether a sample
contains E. multilocularis or E. granulosus in 4 different
ways using our new PCR-RFLP protocol. It is also possible
to perform a sequential double digest using TsoI and
1 of the other 3 restriction enzymes (MboI, MboII, or
AccI). By doing so, one can decide rapidly whether it is
E. multilocularis or E. granulosus by visualizing DNA
fragments in a single reaction. Moreover, combinations
of these enzymes can also be used to decide whether the
sample contains E. shiquicus (digestion is possible only
with MboII and TsoI), E. oligarthus (digestion is possible
only with MboI), or the other 3 species (for E. ortleppi, E.
canadensis, and E. vogeli, digestion is possible only with
MboII) (Table).
Although there are numerous studies on the
molecular discrimination of Echinococcus species utilizing
sequencing, PCR-RFLP, and multiplex PCR, our study
provides: 1) an alternative procedure using a single
PCR reaction for amplification of the marker genomic
region in 7 Echinococcus species, and 2) a PCR-RFLP
method that can potentially identify 7 Echinococcus
species using 4 restriction enzymes. In this study, the
method was successfully applied for the identification of

Table. Positions of restriction enzyme sites in amplified genomic region for different
species of Echinococcus.
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Restriction enzymes

AccI

MboI

MboII

TsoI

E. multilocularis (AB018440.2)

217

89

690

–

E. granulosus (AF297617.1)

–

–

–

362

E. oligarthus (AB208545.1)

–

40

–

–

E. shiquicus (AB208064.1)

–

–

691

20

E. ortleppi (AB235846.1)

–

–

689

–

E. canadensis (AB208063.1)

–

–

695

–

E. vogeli (AB208546.1)

–

–

686

–

ŞAKALAR et al. / Turk J Med Sci
E. multilocularis and E. granulosus, and further studies
for the application of this method to identify the other 5
Echinococcus species are warranted.
In conclusion, we developed a new PCR-RFLP protocol
for the detection and discrimination of E. granulosus and E.
multilocularis using the genomic region containing the last
part of a large ribosomal RNA gene, the cysteine tRNA gene,
and the beginning of a small ribosomal RNA gene as the
marker and making use of a novel set of restriction enzymes.

The new PCR-RFLP protocol may be used potentially
for other Echinococcus species including E. oligarthus, E.
shiquicus, E. ortleppi, E. canadensis, and E. vogeli.
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